US-China Collab to Deliver Multiplexed Solutions for mRNA Vaccine and Cell & Gene Therapy

US-China collaboration to deliver multiplexed solutions for mRNA vaccine and cell & gene therapy

Overview

Partnership addresses biopharmaceutical industry’s urgent need for improved in-process and QC testing tools for these rapidly evolving application fields US-based InDevR, Inc., a leading provider of analytical tools for vaccine quality control and testing, has teamed up with Sino Biological, Inc., a biotechnological firm listed on the Shenzhen stock exchange, which specialises in biological research reagents and related technical services.

Aim for This Partnership

This partnership aims to speed up the development of multiplex assays for a variety of applications in vaccine production, mRNA therapies, and cell and gene therapy.

Post Collaboration

• As part of the collaboration, Sino Biological’s comprehensive range of high-quality antibodies, antigens, and other reagents will be made available for use on InDevR’s VaxArray Platform. 
• This platform is widely used by biopharmaceutical companies globally for its ability to perform multiplex assays, which help simplify, standardise, and accelerate the development, optimisation, and scaling of new vaccine formulations.

The alliance intends to develop advanced analytical tools to support breakthroughs in mRNA vaccine technology, vaccine development, and the fast-growing field of cell and gene therapy.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!